Pluri

Pluri has entered into a securities purchase agreement with a healthcare-focused institutional investor. Under the deal, the investor will acquire 2,228,940 ordinary shares at a price of $1.50 per share.

Foodtech company Ever After Foods, controlled by Israeli biotech giant Pluri, is acquiring the Belgian firm Fishway and securing a $2 million strategic investment to scale its cultivated protein production platform.